Communicable Disease Control
"Communicable Disease Control" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Programs of surveillance designed to prevent the transmission of disease by any means from person to person or from animal to man.
Descriptor ID |
D003140
|
MeSH Number(s) |
N06.850.780.200
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Communicable Disease Control".
Below are MeSH descriptors whose meaning is more specific than "Communicable Disease Control".
This graph shows the total number of publications written about "Communicable Disease Control" by people in this website by year, and whether "Communicable Disease Control" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 1 | 0 | 1 |
2005 | 2 | 0 | 2 |
2006 | 0 | 2 | 2 |
2007 | 3 | 0 | 3 |
2008 | 0 | 1 | 1 |
2009 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2012 | 1 | 1 | 2 |
2013 | 2 | 0 | 2 |
2014 | 0 | 1 | 1 |
2015 | 1 | 0 | 1 |
2017 | 1 | 1 | 2 |
2018 | 1 | 0 | 1 |
2019 | 2 | 0 | 2 |
2020 | 1 | 2 | 3 |
2021 | 2 | 4 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Communicable Disease Control" by people in Profiles.
-
Gordon MN, Heneka MT, Le Page LM, Limberger C, Morgan D, Tenner AJ, Terrando N, Willette AA, Willette SA. Impact of COVID-19 on the Onset and Progression of Alzheimer's Disease and Related Dementias: A Roadmap for Future Research. Alzheimers Dement. 2022 05; 18(5):1038-1046.
-
Parry G, Provost LP, Provost SM, Little K, Perla RJ. A hybrid Shewhart chart for visualizing and learning from epidemic data. Int J Qual Health Care. 2021 Dec 04; 33(4).
-
Nwosu BU, Al-Halbouni L, Parajuli S, Jasmin G, Zitek-Morrison E, Barton BA. COVID-19 Pandemic and Pediatric Type 1 Diabetes: No Significant Change in Glycemic Control During The Pandemic Lockdown of 2020. Front Endocrinol (Lausanne). 2021; 12:703905.
-
Williams CH, Scott EM, Dorfman JD, Simon BJ. Traumatic Injury Under COVID-19 Stay-at-Home Advisory: Experience of a New England Trauma Center. J Surg Res. 2022 01; 269:165-170.
-
Tomaino SCM, Cipolletta S, Kostova Z, Todorova I. Stories of Life during the First Wave of the COVID-19 Pandemic in Italy: A Qualitative Study. Int J Environ Res Public Health. 2021 Jul 18; 18(14).
-
Hagan KK, Javed Z, Cainzos-Achirica M, Sostman D, Vahidy FS, Valero-Elizondo J, Acquah I, Yahya T, Kash B, Andrieni JD, Dubey P, Hyder AA, Nasir K. Social Determinants of Adherence to COVID-19 Risk Mitigation Measures Among Adults With Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2021 06; 14(6):e008118.
-
Baptista MC, Burton WN, Pawlecki B, Pransky G. A Physician's Guide for Workers' Return to Work During COVID-19 Pandemic. J Occup Environ Med. 2021 Mar 01; 63(3):199-220.
-
Davidson BL, Tapson VF, Irwin RS, French CL, Elliott CG, Levi M. Pharyngeal Antisepsis to Reduce COVID-19 Pneumonia. Am J Med. 2021 03; 134(3):297-298.
-
Taylor T, Das R, Mueller K, Pransky G, Christian J, Orford R, Blink R. Safely Returning America to Work: Part I: General Guidance for Employers. J Occup Environ Med. 2020 09; 62(9):771-779.
-
Burgess C, Miller CJ, Franz A, Abel EA, Gyulai L, Osser D, Smith EG, Connolly SL, Krawczyk L, Bauer M, Godleski L. Practical lessons learned for assessing and treating bipolar disorder via telehealth modalities during the COVID-19 pandemic. Bipolar Disord. 2020 09; 22(6):556-557.